| Title |
Author |
Type |
Date |
Words |
| Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States. |
|
|
Jun 17, 2013 |
2712 |
| Elcelyx Therapeutics to Present Clinical Data on NewMet(TM) in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions. |
|
|
Jun 14, 2013 |
618 |
| White rice could cause diabetes. |
|
|
Jun 14, 2013 |
282 |
| 15-minute walk after meals could help cut type 2 diabetes risk. |
|
|
Jun 13, 2013 |
374 |
| Dealing with diabetes; Every three minutes in the UK, somebody is diagnosed with either Type 1 or Type 2 diabetes. In Diabetes Awareness Week (June 9-15), ABI JACKSON asks those in the know for their advice on living with the condition. |
|
|
Jun 12, 2013 |
1736 |
| Dealing with diabetes; Every three minutes in the UK, somebody is diagnosed with either Type 1 or Type 2 diabetes. In Diabetes Awareness Week (June 9-15), ABI JACKSON asks those in the know for their advice on living with the condition. |
|
|
Jun 11, 2013 |
1568 |
| Dealing with diabetes; Every three minutes in the UK, somebody is diagnosed with either Type 1 or Type 2 diabetes. In Diabetes Awareness Week (June 9-15), ABI JACKSON asks those in the know for their advice on living with the condition. |
|
|
Jun 11, 2013 |
1736 |
| Dealing with diabetes; Every three minutes in the UK, somebody is diagnosed with either Type 1 or Type 2 diabetes. In Diabetes Awareness Week (June 9-15), ABI JACKSON asks those in the know for their advice on living with the condition. |
|
|
Jun 11, 2013 |
1733 |
| Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations on Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions. |
|
|
Jun 11, 2013 |
2597 |
| Type 2 diabetes packs available in stores. |
|
|
Jun 8, 2013 |
145 |
| New Guidelines From the American Association of Clinical Endocrinologists (AACE) Identify Welchol (colesevelam HCI) for Lowering Both A1C and LDL-Cholesterol in Patients with Type 2 Diabetes. |
|
|
Jun 6, 2013 |
1807 |
| Healthy heart important for proper brain functioning. |
|
|
Jun 5, 2013 |
467 |
| Heart Health Matters to Your Brain. |
|
|
Jun 5, 2013 |
550 |
| Reduction in BMI cuts diabetes risk in obese teens. |
|
|
Jun 5, 2013 |
420 |
| Night shift workers likelier to have Type 2 diabetes. |
|
|
Jun 4, 2013 |
333 |
| Profil Institute's Sr. Scientific Director Publishes Textbook on New and Emerging Therapeutics for Type 2 Diabetes. |
|
|
Jun 4, 2013 |
807 |
| Valeritas Closes $100 Million Financing. |
|
|
Jun 4, 2013 |
1026 |
| Patients with Type 2 Diabetes or Hypertension Must Be Evaluated for Sleep Apnea. |
|
|
Jun 3, 2013 |
821 |
| Soccer Training Improves Heart Health of Men with Type 2 Diabetes. |
|
|
May 31, 2013 |
422 |
| Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes. |
|
|
May 29, 2013 |
785 |
| Adult Patients in England and Wales to Gain Access to First-in-Class Type 2 Diabetes Treatment. |
|
|
May 29, 2013 |
3101 |
| Making a Move to smash the risk of illness; A project in County Durham is trying to reverse some of the country's worst health rates through exercise. GEORGE COLLINS reports. |
|
|
May 28, 2013 |
626 |
| PreDx Test Now Available With Finger Stick Collection Method. |
|
|
May 28, 2013 |
969 |
| Kids with Type 2 diabetes at greater risk of developing heart, kidney problems. |
|
|
May 25, 2013 |
362 |
| Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance. |
|
|
May 22, 2013 |
1775 |
| Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes. |
|
|
May 20, 2013 |
1013 |
| Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. |
|
Clinical report |
May 20, 2013 |
1173 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1719 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1786 |
| HELP CHANGE THE FUTURE FOR PEOPLE WITH TYPE 2 DIABETES. |
|
|
May 15, 2013 |
274 |
| Low melatonin levels tied to diabetes risk. |
|
|
May 11, 2013 |
295 |
| Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs. |
|
|
May 9, 2013 |
1277 |
| Canada,United States : Merck and Celebrity Chef Art Smith Cook Up a Recipe for Better Type 2 Diabetes Management. |
|
|
May 8, 2013 |
438 |
| Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management. |
|
|
May 7, 2013 |
1290 |
| Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress. |
|
|
May 6, 2013 |
2333 |
| How type 2 diabetes develops. |
|
|
May 4, 2013 |
399 |
| Loss is your gain; Obesity can cause or exacerbate a plethora of conditions, such as asthma, high blood pressure, heart disease, angina, sleep apnoea, fatty liver and type 2 diabetes. But can these be cured with a change in lifestyle? KAREN WILSON reports. |
|
|
May 3, 2013 |
1576 |
| Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases. |
|
|
May 2, 2013 |
540 |
| Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes. |
|
|
May 2, 2013 |
1333 |
| New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas' V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes. |
|
Clinical report |
May 2, 2013 |
1722 |
| Green tea can help lose weight and regulate glucose in type 2 diabetes. |
|
|
Apr 30, 2013 |
500 |
| Writer Randy Jernigan Tackles Issues of Type 2 Diabetes and Childhood Obesity in New Cookbook. |
|
|
Apr 30, 2013 |
233 |
| One sugary soft drink a day can up diabetes risk by 22%. |
|
|
Apr 27, 2013 |
386 |
| One sugar-sweetened soft drink a day can up diabetes risk by 22 pc. |
|
|
Apr 25, 2013 |
405 |
| Tesco helps in diabetes fight; TOXTETH Store joins with charity t. |
|
|
Apr 23, 2013 |
260 |
| Italy : Multiscale Immune System Simulator for the ONset of Type 2 Diabetes integrating genetic, metabolic and nutritional data. |
|
|
Apr 19, 2013 |
324 |
| Tesco's shot in the arm boosts charity. |
|
|
Apr 16, 2013 |
371 |
| FDA approves canagliflozin for type 2 diabetes: agency is requiring five postmarketing studies, including a cardiovascular outcomes trial. |
Ault, Alicia |
|
Apr 15, 2013 |
360 |
| Green coffee extract helps control blood sugar levels. |
|
|
Apr 10, 2013 |
510 |
| South Asian expats prone to type 2 diabetes: HMC study. |
|
|
Apr 8, 2013 |
521 |
| New Study Released by the Journal of Medicinal Food Claims that Emulin(TM) is effective in lowering blood glucose levels in type 2 diabetes. |
|
|
Apr 2, 2013 |
695 |
| TERISA targets diabetes as new market for ranolazine. |
Jancin, Bruce |
|
Apr 1, 2013 |
739 |
| Benefits of beans in type 2 diabetes. |
Mangels, Reed |
Brief article |
Apr 1, 2013 |
304 |
| Potential benefits of honey in type 2 diabetes mellitus: a review. |
Kadirvelu, Amudha; Gurtu, Sunil |
|
Apr 1, 2013 |
7920 |
| U.S. FDA Approves INVOKANA(TM) (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes. |
|
|
Mar 29, 2013 |
3789 |
| European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment. |
|
|
Mar 26, 2013 |
1248 |
| Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment. |
|
|
Mar 25, 2013 |
1274 |
| Joslin Diabetes Center Seeks To Catalyze The Prevention Of Type 2 Diabetes. |
|
|
Mar 25, 2013 |
592 |
| Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes. |
|
|
Mar 21, 2013 |
1580 |
| Modifying function of genes could reduce risk of diabetes. |
|
|
Mar 20, 2013 |
390 |
| China,Germany : Merck Serono Announces Collaboration With Bristol-Myers Squibb for Glucophage in China for Treatment of Type 2 Diabetes. |
|
|
Mar 20, 2013 |
446 |
| Germany : Merck Announces Collaboration With Bristol-Myers Squibb for Glucophage in China for Treatment of Type 2 Diabetes. |
|
|
Mar 20, 2013 |
434 |
| Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta (linagliptin) tablets in patients with type 2 diabetes and albuminuria. |
|
|
Mar 19, 2013 |
2019 |
| Free copy of diabetes leaflet; Yousay IN YOUR OPINION... |
|
|
Mar 18, 2013 |
120 |
| Help about diabetes; & COMMENT DEBATE YOUR LETTERS TO THE NATIONAL NEWSPAPER OF WALES. |
|
|
Mar 14, 2013 |
167 |
| Doctors Agree Small Lifestyle Changes Can Improve Outcomes of Patients with Type 2 Diabetes, National Survey Finds. |
|
|
Mar 14, 2013 |
815 |
| Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes. |
|
|
Mar 8, 2013 |
1170 |
| Novo Nordisk and Paula Deen Offer Chance to Experience Paula's Approach to Healthier Living. |
|
|
Mar 7, 2013 |
882 |
| GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier[R] Therapy in Brazil. |
|
|
Mar 6, 2013 |
955 |
| New Clinical Guidelines for Older People With Type 2 Diabetes Launched to Help Avert European Care Crisis. |
|
|
Mar 5, 2013 |
863 |
| diabetes is at record. |
|
|
Mar 4, 2013 |
237 |
| DIABETES IS AT RECORD. |
|
|
Mar 4, 2013 |
236 |
| UK DIABETES CASES A RECORD 3 MILLION; Experts warn of public health emergency. |
|
|
Mar 4, 2013 |
357 |
| Three million diagnosed with diabetes; Partnership to identify people at high risk. |
|
|
Mar 4, 2013 |
486 |
| Victims of diabetes hit a high of three million. |
|
|
Mar 4, 2013 |
383 |
| Factors leading to inflammation in Type 2 diabetes, cancer identified. |
|
|
Mar 2, 2013 |
364 |
| Glycemic biomarkers as tools for diagnosis and monitoring of diabetes. |
Gupta, Manjula K. |
Cover story |
Mar 1, 2013 |
2923 |
| Mitochondria, body fat and type 2 diabetes: what is the connection? |
|
Brief article |
Mar 1, 2013 |
163 |
| Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. |
|
Brief article |
Mar 1, 2013 |
177 |
| Sit less and move more to cut diabetes risk. |
|
|
Feb 28, 2013 |
446 |
| GI Dynamics Announces Commercial Availability of EndoBarrier[R] Therapy in Israel for the Treatment of Type 2 Diabetes and/or Obesity. |
|
|
Feb 27, 2013 |
1040 |
| New Harvard study reports walnut consumption to be linked to lower risk of type 2 diabetes in women. |
|
Clinical report |
Feb 27, 2013 |
1222 |
| New Meta-Analysis Demonstrates the Benefits of a Low-Carb Diet, like the Atkins Diet, in the Management of Type 2 Diabetes. |
|
Disease/Disorder overview |
Feb 26, 2013 |
656 |
| Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA. |
|
|
Feb 19, 2013 |
1876 |
| Nation's obesity, diabetes epidemics fuel a new threat: liver disease. |
Zoler, Mitchel L. |
|
Feb 15, 2013 |
2621 |
| Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes. |
Zhang, Chang-Hua; Xu, Guo-Liang; Liu, Yu-Hui; Rao, Yi; Yu, Ri-Yue; Zhang, Zhong-Wei; Wang, Yue-Sheng |
Report |
Feb 15, 2013 |
7240 |
| As Type 2 Diabetes Grows at Alarming Rates, Pharmaceutical Companies Will Face New Challenges and New Opportunities. |
|
|
Feb 6, 2013 |
1159 |
| Diabetics treated with insulin 'at greater risk of health complications'. |
|
|
Feb 5, 2013 |
439 |
| Research and Markets: Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth. |
|
|
Feb 4, 2013 |
732 |
| Once-Daily Lyxumia (lixisenatide) Approved for Treatment of Type 2 Diabetes in Europe. |
|
|
Feb 4, 2013 |
1359 |
| Culprit behind obesity-associated conditions identified. |
|
|
Feb 1, 2013 |
535 |
| Scientists Identify Culprit in Obesity-Associated High Blood Pressure. |
|
|
Feb 1, 2013 |
640 |
| In the Battle Against Rampant Diabetes, Reducing Hunger Hormone Ghrelin May Be the Ultimate Solution, says Noted Surgeon Dr. Michael Feiz. |
|
|
Feb 1, 2013 |
579 |
| A Bayesian joint analysis and imputation model for longitudinal data: an application in type 2 diabetes drug effect comparison. |
Bhattacharjee, Atanu |
|
Feb 1, 2013 |
2678 |
| Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the strong heart study. |
|
Brief article |
Feb 1, 2013 |
258 |
| Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. |
|
Abstract |
Feb 1, 2013 |
308 |
| Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. |
|
Author abstract |
Feb 1, 2013 |
220 |
| Postprandial glucose regulation: new data and new implications. |
|
Author abstract |
Feb 1, 2013 |
395 |
| Bariatric surgery reduced vascular events in diabetes. |
Zoler, Mitchel L. |
|
Feb 1, 2013 |
597 |
| FDA panel backs canagliflozin for type 2 diabetes: committee votes 10-5 for approval, but some cite safety concerns and cardiovascular risks. |
Mechcatie, Elizabeth |
|
Feb 1, 2013 |
1328 |
| Type-3 diabetes: the link between insulin and Alzheimer's disease. |
|
|
Feb 1, 2013 |
697 |
| Persistent organic pollutants and type 2 diabetes: a prospective analysis in the Nurses' health study and meta-analysis. |
Wu, Hongyu; Bertrand, Kimberly A.; Choi, Anna L.; Hu, Frank B.; Laden, Francine; Grandjean, Philippe |
Report |
Feb 1, 2013 |
17015 |
| Long-term exposure to road traffic noise and incident diabetes: a cohort study. |
Sorensen, Mette; Andersen, Zorana J.; Nordsborg, Rikke B.; Becker, Thomas; Tjonneland, Anne; Overvad |
Report |
Feb 1, 2013 |
7127 |
| Novo Nordisk Supports Five Madison/Milwaukee-Based Organizations In Fight Against Diabetes. |
|
|
Jan 29, 2013 |
757 |
| Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl). |
|
|
Jan 28, 2013 |
2814 |
| Furiex Confirms Takeda's Receipt of FDA Approval of NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the Treatment of Type 2 Diabetes. |
|
|
Jan 26, 2013 |
1009 |
| Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl). |
|
|
Jan 25, 2013 |
2821 |
| Women have to work harder than men to reap similar workout benefits. |
|
Clinical report |
Jan 24, 2013 |
361 |
| Novo Nordisk Launches New Program To Recognize People With Type 2 Diabetes Who Give Back To Their Communities. |
|
|
Jan 22, 2013 |
1252 |
| Congresswoman Barbara Lee Visits Tethys Bioscience. |
|
|
Jan 22, 2013 |
800 |
| GI Dynamics, Inc. Initiates U.S. Pivotal Clinical Trial of EndoBarrier[R]. |
|
|
Jan 15, 2013 |
1166 |
| FDA Advisory Committee Recommends Approval of Canagliflozin for Treatment of Adults with Type 2 Diabetes. |
|
|
Jan 10, 2013 |
1266 |
| Second Genome Sponsors American Gut Initiative to Identify Links Between Type 2 Diabetes and the Human Microbiome. |
|
|
Jan 7, 2013 |
446 |
| Plasma vitamin c level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European Prospective Investigation of Cancer--Norfolk prospective study. |
|
Brief article |
Jan 1, 2013 |
308 |
| Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. |
|
Brief article |
Jan 1, 2013 |
311 |
| PCBs and diabetes: pinning down mechanisms. |
Weinhold, Bob |
|
Jan 1, 2013 |
478 |
| Research and Markets: Type 2 Diabetes (Event Driven) - Current and Emerging Therapies. |
|
|
Dec 20, 2012 |
323 |
| ProMining Therapeutics, Ltd. Announced a Collaboration With Roche for the Discovery of Small Molecule Therapeutics for the Treatment of Type 2 Diabetes Using ProMining's CavitIIRx Platform Technology. |
|
|
Dec 17, 2012 |
431 |
| Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes. |
|
|
Dec 12, 2012 |
1162 |
| Patients need more information on diabetes, doctors say. |
|
|
Dec 12, 2012 |
454 |
| Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders. |
|
|
Dec 7, 2012 |
1453 |
| 3-4 cups of coffee daily may help cut diabetes risk by up to 25 pc. |
|
|
Dec 5, 2012 |
557 |
| The 12nd Colloque Medecine et Recherche of the Fondation IPSEN in the Endocrinology series: "Hormones, intrauterine health and programming". |
|
|
Dec 5, 2012 |
1614 |
| Diabetes Winter Health Guide: Holiday and Cold Weather Safety Tips. |
|
|
Nov 30, 2012 |
1214 |
| CeQur Receives CE Mark for PaQ Insulin Delivery Device. |
|
|
Nov 27, 2012 |
620 |
| CeQur Receives CE Mark for PaQ Insulin Delivery Device. |
|
|
Nov 27, 2012 |
593 |
| Rite Aid Now Offers Diabetes Control Program in Cleveland to Help Fight Diabetes Crisis. |
|
|
Nov 16, 2012 |
984 |
| Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes. |
|
|
Nov 15, 2012 |
1235 |
| Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes. |
|
|
Nov 15, 2012 |
716 |
| Aliskiren: no benefit in type 2 diabetes with hypertension. |
Splete, Heidi |
Clinical report |
Nov 15, 2012 |
584 |
| Weight gain after diabetes diagnosis is deadly. |
Zoler, Mitchel L. |
|
Nov 15, 2012 |
417 |
| Insulin degludec beats sitagliptin as type 2 add-on therapy. |
|
Clinical report |
Nov 15, 2012 |
654 |
| Searching for the right type 2 diabetes treatment. |
Zoler, Mitchel |
|
Nov 15, 2012 |
495 |
| Forxiga[TM] (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes. |
|
|
Nov 14, 2012 |
1990 |
| UnitedHealthcare Expands Reach of Diabetes Prevention and Control Programs to Las Vegas and Clark County. |
|
|
Nov 13, 2012 |
1503 |
| Novant Health Urges Adults to Assess Their Risk on World Diabetes Day. |
|
|
Nov 13, 2012 |
981 |
| Study: Overweight Emirati students at risk of Type 2 diabetes. |
|
|
Nov 12, 2012 |
429 |
| Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice. |
|
|
Nov 12, 2012 |
1434 |
| Physical activity Eo,e1/4o[umlaut]crucial to combat diabetesEo,e1/4,ao. |
|
|
Nov 11, 2012 |
753 |
| CDC Awards Grant to Diabetes Prevention and Control Alliance to Expand National Program to Prevent Type 2 Diabetes. |
|
|
Nov 9, 2012 |
863 |
| LILLY (ELI) & COMPANY - Cardiovascular outcome study on Tradjenta (linagliptin). |
|
|
Nov 8, 2012 |
2026 |
| UnitedHealth Group Survey Reveals Americans Know Type 2 Diabetes is Largely Preventable, Suggests Country is Ready for Action. |
|
Survey |
Nov 8, 2012 |
1193 |
| Small lifestyle changes key to diabetes crisis. |
|
|
Nov 5, 2012 |
679 |
| Hypoglycemia: insulin degludec edges glargine. |
Zoler, Mitchel L. |
|
Nov 1, 2012 |
872 |
| Add-On glargine bests sitagliptin for [HbA.sub.lc] reduction. |
Tucker, Miriam E. |
Clinical report |
Nov 1, 2012 |
999 |
| Research and Markets: Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2012. |
|
Clinical report |
Nov 1, 2012 |
279 |
| UnitedHealth Group Survey Reveals Americans Know Type 2 Diabetes is Largely Preventable, Suggests Country is Ready for Action. |
|
Survey |
Nov 1, 2012 |
1193 |
| Secondhand smoke linked to diabetes and obesity. |
Klatz, Ronald; Goldman, Robert |
Brief article |
Nov 1, 2012 |
343 |
| Boost fruits and vegetables to reduce diabetes risk. |
Klatz, Ronald; Goldman, Robert |
Brief article |
Nov 1, 2012 |
163 |
| Almonds improve glycemic control in type 2 diabetics. |
Gaby, Alan R. |
|
Nov 1, 2012 |
331 |
| More about nuts and type 2 diabetes. |
Gaby, Alan R. |
Brief article |
Nov 1, 2012 |
184 |
| Type 2 diabetes, insulin resistance, obesity, and blood sugar control. |
Yates, Beverly |
Report |
Nov 1, 2012 |
1891 |
| Ticking time-bombs. |
Seggie, Janet |
|
Nov 1, 2012 |
366 |
| High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: Baseline data of a study in Bellville, Cape Town. |
Erasmus, Rajiv T.; Soita, David J.; Hassan, Mogamat S.; Blanco-Blanco, Ernesto; Vergotine, Zelda; Ke |
Report |
Nov 1, 2012 |
3842 |
| Metformin makes headline news. |
Faloon, William |
Report |
Nov 1, 2012 |
6183 |
| Australia,Luxembourg,United States : GI Dynamics, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of EndoBarrier. |
|
|
Oct 30, 2012 |
426 |
| GI Dynamics, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of EndoBarrier[R]. |
|
|
Oct 29, 2012 |
1104 |
| Diet may not help cut risk of heart attack in diabetics. |
|
|
Oct 28, 2012 |
296 |
| New genes involved in biology of adult obesity discovered. |
|
|
Oct 26, 2012 |
519 |
| New Genes Discovered for Adult BMI Levels. |
|
|
Oct 25, 2012 |
898 |
| I'm sorry I let this happen; ARLENE'S STORY. |
|
|
Oct 23, 2012 |
440 |
| The Type 2 Diabetes Drug Market in South Korea is Expected to Grow to More Than $550 Million in 2016. |
|
|
Oct 22, 2012 |
593 |
| LILLY (ELI) & COMPANY - Dula Topline Release. |
|
|
Oct 22, 2012 |
1293 |
| Weight loss alone 'doesn't lower heart disease risk in diabetics'. |
|
|
Oct 20, 2012 |
208 |
| Weight Loss Does Not Lower Heart Disease Risk Among Type 2 Diabetes Patients. |
|
|
Oct 20, 2012 |
435 |
| Weight loss does not lower heart disease risk from type 2 diabetes. |
|
|
Oct 19, 2012 |
104 |
| Research and Markets: Type 2 Diabetes - Pipeline Review, H2 2012. |
|
|
Oct 17, 2012 |
376 |
| Molina Healthcare Selected to Participate in Prediabetes Program Implementation. |
|
|
Oct 16, 2012 |
616 |
| Molina Healthcare Selected to Participate in Prediabetes Program Implementation. |
|
|
Oct 16, 2012 |
616 |
| New Study Associates Blood Glucose Monitoring With Lower A1C Levels and Greater Medication Adherence in Type 2 Diabetes Patients Who Don't Use Insulin. |
|
Clinical report |
Oct 16, 2012 |
608 |
| The Type 2 Diabetes Drug Market Will Almost Double Over the Next Decade, Increasing from $26 Billion in 2011 to Nearly $50 Billion in 2021. |
|
|
Oct 15, 2012 |
521 |
| Data don't support mass T2 diabetes screening. |
Sullivan, Michele G. |
|
Oct 15, 2012 |
728 |
| Roux-en-Y surgery may reverse type 2 diabetes. |
Sullivan, Michele G. |
|
Oct 15, 2012 |
574 |
| Canagliflozin improved glycemic control, BP. |
Zoler, Mitchel L. |
|
Oct 15, 2012 |
681 |
| Left Ventricular Dysfunction common in type 2. |
Sullivan, Michele G. |
Clinical report |
Oct 15, 2012 |
614 |
| Exercise can help lower premature aging of diabetics' cardiovascular systems. |
|
|
Oct 12, 2012 |
448 |
| Cardiometabolic Health Congress Keynote Speaker to Present Cutting-Edge Data on Surgical Management of T2DM in Severely Obese Patients. |
|
|
Oct 11, 2012 |
470 |
| Rite Aid Now Offers Diabetes Control Program on Long Island to Help Fight National Diabetes Crisis. |
|
|
Oct 11, 2012 |
942 |
| Florida Blue Partners with CDC and AHIP to Help Prevent Type 2 Diabetes in Florida. |
|
|
Oct 11, 2012 |
701 |
| Novo Nordisk Supports Four Detroit-Based Organizations In Fight Against Diabetes. |
|
|
Oct 11, 2012 |
711 |
| EmblemHealth Partners with CDC and AHIP to Bring National Program to Prevent Type 2 Diabetes to New York City. |
|
|
Oct 10, 2012 |
730 |
| Aetna Receives Award To Prevent Type 2 Diabetes In Texas. |
|
|
Oct 10, 2012 |
713 |
| After diabetes during pregnancy, healthy diet linked to reduced type 2 diabetes risk. |
|
Brief article |
Oct 9, 2012 |
103 |
| United States : VOXIVA to combat Type 2 diabetes with CARE4LIFE. |
|
|
Oct 7, 2012 |
141 |
| Research and Markets: Key Findings from Treatment Algorithms: Type 2 Diabetes. |
|
|
Oct 5, 2012 |
395 |
| 14 novel biomarkers for type 2 diabetes identified. |
|
|
Oct 5, 2012 |
439 |
| Research and Markets: Oral Therapies for Type 2 Diabetes: Physician and Payer Perspectives on the Dynamics in the Chinese and South Korean Markets. |
|
|
Oct 3, 2012 |
383 |
| Phase IIb Data Showed Merck's Investigational Once-Weekly DPP-4 Inhibitor MK-3102 Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes. |
|
|
Oct 3, 2012 |
1035 |
| Pooled analysis demonstrated reductions in systolic blood pressure with empagliflozin, an investigational SGLT-2 inhibitor, independent of changes in blood glucose and weight in adults with type 2 diabetes. |
|
|
Oct 2, 2012 |
1855 |
| Researchers present findings on new drug target for treatment of type 2 diabetes. |
|
|
Oct 2, 2012 |
817 |
| Lilly and Boehringer Ingelheim Present Health Outcomes Data for Investigational Novel Basal Insulin Analogue. |
|
Clinical report |
Oct 2, 2012 |
1844 |
| Studies assess linagliptin treatment in adults with type 2 diabetes (T2D), as well as add-on to basal insulin therapy. |
|
|
Oct 2, 2012 |
3010 |
| Ask Dr. Nan. |
|
|
Oct 1, 2012 |
545 |
| Preventing type 2 diabetes: a role for every practitioner. |
Hill, Jill |
|
Oct 1, 2012 |
1803 |
| Diabetes screening as part of a vascular disease risk management programme. |
Bartram, Sara; Rigby, David |
|
Oct 1, 2012 |
3232 |
| Intarcia to Present Analysis of Dose Selection for Global ITCA 650 Phase 3 Program for Type 2 Diabetes at EASD. |
|
Clinical report |
Sep 28, 2012 |
633 |
| Gut bacteria can indicate risk of developing diabetes. |
|
|
Sep 27, 2012 |
524 |
| Amylin Launches This Week I Will Pledge Campaign to Encourage Adults with Type 2 Diabetes to Set Weekly Goals While Giving Back to Diabetes Community. |
|
|
Sep 27, 2012 |
1902 |
| CSL drug candidate in diabetes research breakthrough. |
|
|
Sep 26, 2012 |
1130 |
| CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes. |
|
Clinical report |
Sep 26, 2012 |
671 |
| CSL drug candidate in diabetes research breakthrough. |
|
|
Sep 26, 2012 |
1134 |
| Hostile Bacteria In Gut A Likely Sign Of Type 2 Diabetes. |
|
|
Sep 26, 2012 |
499 |
| Focus on diabetes awareness; Event at DCU Center stresses diagnosis, education. |
|
|
Sep 23, 2012 |
806 |
| Switzerland : Novartis announces two CHMP positive opinions for new indications of Galvus and Eucreas combined with other diabetes treatments. |
|
|
Sep 22, 2012 |
227 |
| Germany : CHMP recommends indication for the use of TrajentaA (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes in Europe. |
|
|
Sep 22, 2012 |
389 |
| Highmark and Healthrageous To Pilot New Digital Diabetes Self-Management Program. |
|
|
Sep 21, 2012 |
584 |
| LILLY (ELI) & COMPANY - Recommended Indication for Trajenta Type 2 Diabetes. |
|
|
Sep 21, 2012 |
1548 |
| People with belly fat 'more prone to Type 2 diabetes'. |
|
|
Sep 19, 2012 |
268 |
| Nutritional Snack and Supplement Company Launches with Focus on Type 2 Diabetes Community. |
|
|
Sep 19, 2012 |
637 |
| Clinical Study Reveals Critical Importance of Measuring LDL-Particles for Patients with Type 2 Diabetes Mellitus. |
|
Clinical report |
Sep 17, 2012 |
569 |
| Bariatric surgery prevents type 2 diabetes in obese. |
Tucker, Miriam E. |
|
Sep 15, 2012 |
798 |
| Diabetes may up breast cancer risk in post-menopausal women. |
|
|
Sep 14, 2012 |
314 |
| Health roadshow; & COMMENT DEBATE YOUR LETTERS TO THE NATIONAL NEWSPAPER OF WALES. |
|
|
Sep 14, 2012 |
230 |
| Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes. |
|
|
Sep 13, 2012 |
3044 |
| Brit people of South Asian descent 'likelier to develop diabetes'. |
|
|
Sep 11, 2012 |
541 |
| 'My diagnosis was the greatest of wake-up calls' Sales rep Rob Lee had no idea he was suffering Type 2 diabetes until a random blood test six years ago. He told Carys Hepworth how that 'bad' news changed his life for the better. |
|
|
Sep 10, 2012 |
434 |
| Gastric bypass surgery helped Lesley lose 56lb. |
|
|
Sep 10, 2012 |
569 |
| Thin isn't always better in diabetes: obese have lower mortality rate than normal-weight people. |
Rosen, Meghan |
Brief article |
Sep 8, 2012 |
245 |
| Renal outreach clinic makes difference in fight against diabetes. |
Lambert, Rachel |
|
Sep 1, 2012 |
463 |
| Postpartum glucose won't predict 6-week diabetes: at the annual scientific sessions of the American Diabetes Association. |
Sullivan, Michele G. |
|
Sep 1, 2012 |
565 |
| Obesity paradox holds in people who develop type 2 diabetes despite normal weight. |
|
|
Sep 1, 2012 |
226 |
| Decade-long diabetes study shuts down. |
|
|
Sep 1, 2012 |
6916 |
| Media release: study reveals good news about the GI of rice. |
|
|
Sep 1, 2012 |
472 |
| Effects of six months of combined aerobic and resistance training for elderly patients with a long history of type 2 diabetes. |
Tan, Sijie; Li, Wei; Wang, Jianxiong |
Report |
Sep 1, 2012 |
6814 |
| Dietary selenium reduces incidence of type 2 diabetes mellitus. |
|
|
Sep 1, 2012 |
431 |
| The Light Study, a New Long-Term Weight Management Research Study, Begins Enrolling Patients at Wake Research Associates in Raleigh, NC. |
|
|
Aug 31, 2012 |
522 |
| Seven million diabetes patients in Pakistan. |
|
|
Aug 31, 2012 |
410 |
| Common virus could give you type 2 diabetes later in life. |
|
|
Aug 29, 2012 |
265 |
| Japan : Launch of TENELIA(R) 20mg Tablets, A DPP-4 Inhibitor for Type 2 Diabetes Mellitus Originating from Japan. |
|
|
Aug 29, 2012 |
213 |
| GI Dynamics, Inc. Announces FDA Conditional Approval for Pivotal Clinical Trial of the EndoBarrier[R]. |
|
|
Aug 23, 2012 |
1137 |
| Excess weight 'most important single contributing factor for diabetes'. |
|
|
Aug 22, 2012 |
394 |
| For Treatment of Type 2 Diabetes, Complete Lack of Coverage of GLP-1 Analogues by Government-Sponsored Programs in Brazil, and Limited Coverage in Mexico, Substantially Restricts Prescribing of These Agents in the Public Setting. |
|
|
Aug 21, 2012 |
706 |
| PhaseBio Pharmaceuticals Initiates a Multicenter, Randomized Placebo and Active Comparator Controlled Phase 2b Trial to Evaluate use of Glymera for the Treatment of Uncontrolled Type 2 Diabetes. |
|
Clinical report |
Aug 21, 2012 |
456 |
| LILLY (ELI) & COMPANY - FDA Approves Updated Prescribing Info for Tradjenta. |
|
|
Aug 20, 2012 |
2572 |
| FDA approves updated prescribing information for Tradjenta (linagliptin) tablets for add-on therapy to insulin in adults with type 2 diabetes. |
|
|
Aug 17, 2012 |
2631 |
| Unigene And Nordic Bioscience Announce Preliminary Selection Of Lead Compound For Treating Type 2 Diabetes. |
|
|
Aug 15, 2012 |
1418 |
| 10 new gene regions linked to type 2 diabetes identified. |
|
|
Aug 13, 2012 |
346 |
| Statin use up age-related cataract risk. |
|
|
Aug 12, 2012 |
481 |
| Nearly half of type 2 diabetes patients suffer acute and chronic pain. |
|
|
Aug 12, 2012 |
529 |
| Weight training may help reduce diabetes risk. |
|
|
Aug 7, 2012 |
362 |
| Bristol-Myers Squibb Foundation Awards $1.6 Million in Grants to Help Communities in India Address Type 2 Diabetes. |
|
|
Aug 6, 2012 |
806 |
| Type 2 diabetic residents can lose weight by fasting. |
|
|
Aug 1, 2012 |
459 |
| Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. |
|
|
Aug 1, 2012 |
316 |
| Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. |
|
Brief article |
Aug 1, 2012 |
171 |
| Weight-loss drug hits diabetes target trifecta. |
Jancin, Bruce |
|
Aug 1, 2012 |
814 |
| Sulfonylureas pose increased mortality risk: in type 2 diabetes, metformin 'should be the first-line agent used to control blood sugar levels.'. |
Jancin, Bruce |
|
Aug 1, 2012 |
618 |
| Glargine, liraglutide neck and neck, except on cost. |
Tucker, Miriam E. |
|
Aug 1, 2012 |
693 |
| Fitness curbs mortality in men with type 2 diabetes. |
Boschert, Sherry |
|
Aug 1, 2012 |
480 |
| One in 70 could be living with undiagnosed type 2 diabetes. |
|
|
Aug 1, 2012 |
146 |
| Curry compound may curb diabetes risk: study. |
|
|
Jul 31, 2012 |
365 |
| Receptor's role in regulating obesity and diabetes identified. |
|
|
Jul 27, 2012 |
475 |
| Furiex Confirms Takeda's Resubmissions of Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone NDAs to the U.S. FDA. |
|
|
Jul 27, 2012 |
1062 |
| LILLY (ELI) & COMPANY - Jentadueto Receives Approval for Type 2 Diabetes in EU. |
|
|
Jul 25, 2012 |
3130 |
| Jentadueto (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with type 2 diabetes in Europe. |
|
|
Jul 25, 2012 |
3300 |
| Cheese slashes diabetes risk by 12pc. |
|
Clinical report |
Jul 24, 2012 |
239 |
| India features in 32-country study on effectiveness of diabetes drug. |
|
|
Jul 24, 2012 |
707 |
| Fast Food Increases Risk of Type 2 Diabetes and Heart Disease. |
|
|
Jul 22, 2012 |
433 |
| Eating eggs doesn't raise diabetes risk. |
|
|
Jul 22, 2012 |
282 |
| Genes that help regulate sex hormones in bloodstream identified. |
|
|
Jul 21, 2012 |
445 |
| Obese diabetics 'can benefit from fasting'. |
|
|
Jul 19, 2012 |
515 |
| How exercise improves heart function in diabetics. |
|
|
Jul 18, 2012 |
598 |
| Vivus Announces FDA Approval of Once Daily Qsymia(TM) (Phentermine and Topiramate Extended-release) Capsules CIV. |
|
|
Jul 17, 2012 |
1995 |
| GI Dynamics, Inc. Announces Further Strengthening of Commercial Foundation for EndoBarrier[R] Therapy and Progress with New Centers in Key Markets. |
|
|
Jul 17, 2012 |
1259 |
| In Brazil and Mexico, Prescribing of DPP-IV Inhibitors for the Treatment of Type 2 Diabetes is Uncommon in the Public Healthcare Setting Due to Lack of Government Funding in Both Countries and High Out-of-Pocket Costs. |
|
|
Jul 17, 2012 |
822 |
| Seminar on safe fasting for diabetics patients. |
|
|
Jul 15, 2012 |
342 |
| FYI From Human Genome Sciences: GlaxoSmithKline Announces Positive Data from Harmony 8 Phase 3 Trial and Completion of Clinical Registration Package for Albiglutide in Type 2 Diabetes. |
|
|
Jul 11, 2012 |
679 |
| Hormone curbs depression-like symptoms in stressed mice. |
|
|
Jul 10, 2012 |
477 |
| MSD launches cookbook for diabetes. |
|
|
Jul 5, 2012 |
553 |
| Diabetes Drugs Could Increase Risk of Bladder Cancer. |
|
|
Jul 4, 2012 |
436 |
| Research and Markets: Humalog (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
|
Jul 2, 2012 |
393 |
| Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention. |
|
|
Jul 2, 2012 |
1216 |
| An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. |
|
Report |
Jul 1, 2012 |
415 |
| Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. |
|
Brief article |
Jul 1, 2012 |
312 |
| Weight-loss drugs forthcoming; needle moves on target trifecta. |
Jancin, Bruce |
|
Jul 1, 2012 |
813 |
| Long-standing diabetes tends to recur after bariatric surgery. |
Jancin, Bruce |
|
Jul 1, 2012 |
458 |
| Obesity linked to surging liver cancer: the slog of internal medicine news digital network. |
Zoler, Mitchel L. |
|
Jul 1, 2012 |
540 |
| Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin Pharmaceuticals. |
|
|
Jun 30, 2012 |
2803 |
| Exercise cuts mobility loss in diabetics. |
|
|
Jun 29, 2012 |
225 |
| Research and Markets: Basen (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
|
Jun 27, 2012 |
374 |
| Research and Markets: ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
|
Jun 27, 2012 |
390 |
| Janssen Submits European Marketing Authorisation Application for Canagliflozin in Type 2 Diabetes. |
|
|
Jun 26, 2012 |
1298 |
| Exposure to secondhand smoke may trigger diabetes and obesity. |
|
|
Jun 26, 2012 |
529 |
| Common diabetes drugs up death risk. |
|
|
Jun 26, 2012 |
465 |
| Low vitamin D levels may up risk of Type 2 diabetes and heart disease. |
|
|
Jun 26, 2012 |
498 |
| Standard aspirin dose may not protect diabetics against blood clots. |
|
Clinical report |
Jun 26, 2012 |
425 |
| Modified weight loss surgery provides Type 2 diabetes reversal. |
|
|
Jun 26, 2012 |
554 |
| Research and Markets: Symlin (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
Report |
Jun 26, 2012 |
418 |
| Research and Markets: Bydureon (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
|
Jun 26, 2012 |
387 |
| Research and Markets: A Product and Pipeline Analysis of the U.S. Type 2 Diabetes Mellitus Market, 2012. |
|
|
Jun 26, 2012 |
302 |
| Lifestyle changes key in diabetes care. |
|
|
Jun 23, 2012 |
391 |
| Research and Markets: Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
|
Jun 22, 2012 |
384 |
| Study Presented at American Society for Metabolic & Bariatric Surgery Meeting Demonstrates Efficacy of EndoBarrier[R] Therapy in Treating Overweight and Mildly Obese Type 2 Diabetes Patients. |
|
|
Jun 22, 2012 |
1157 |
| Research and Markets: Market and Product Forecasts: Non-Insulin Antidiabetics - Incretin Mimetics Face off in type 2 Diabetes - Updated 2012 Report. |
|
|
Jun 22, 2012 |
380 |
| Investigational Ultra-long-acting Insulin Degludec Reduces Rates of Nocturnal Hypoglycaemia in Type 2 Diabetes Patients Versus Insulin Glargine. |
|
|
Jun 22, 2012 |
516 |
| Research and Markets: Januvia (Type 2 Diabetes) - Analysis and Forecasts to 2020. |
|
Report |
Jun 20, 2012 |
429 |
| Furiex Confirms Takeda's Announcement on the Acceptance of the EMA Submissions for Two Fixed-Dose Alogliptin Combination Therapies for the Treatment of Type 2 Diabetes. |
|
|
Jun 19, 2012 |
988 |
| Takeda Announces Acceptance of European Medicines Agency Submissions for Two Fixed-Dose Combination Therapies, Alogliptin and Pioglitazone and Alogliptin and Metformin, for the Treatment of Type 2 Diabetes. |
|
|
Jun 19, 2012 |
1114 |
| New gene associated with lean diabetics identified. |
|
|
Jun 16, 2012 |
415 |
| Cook to better health. |
|
|
Jun 16, 2012 |
156 |
| Early insulin failed to prevent cardiac events: from the annual scientific sessions of the American Diabetes Association. |
Tucker, Miriam E. |
|
Jun 15, 2012 |
1394 |
